Applied Genetic Technologies Corporation (NASDAQ: AGTC) stock closed at 0.735 per share at the end of the most recent trading day (a 19.12% change compared to the prior day closing price) with a volume of 331.10K shares and market capitalization of 37.29M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Applied Genetic Technologies Corporation CEO is Susan B. Washer.

The one-year performance of Applied Genetic Technologies Corporation stock is -85.02%, while year-to-date (YTD) performance is -61.32%. AGTC stock has a five-year performance of -85.87%. Its 52-week range is between 0.58 and 4.59, which gives AGTC stock a 52-week price range ratio of 3.87%

Applied Genetic Technologies Corporation currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.67, a price-to-sale (PS) ratio of 74.58, a price to cashflow ratio of 1.80, a PEG ratio of 2.32, a ROA of -59.81%, a ROC of -65.79% and a ROE of -90.45%. The company’s profit margin is -80.91%, its EBITDA margin is -12 147.80%, and its revenue ttm is $500.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Applied Genetic Technologies Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.42 for the next earnings report. Applied Genetic Technologies Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Applied Genetic Technologies Corporation is Strong Buy (1), with a target price of $10.4, which is +1 314.97% compared to the current price. The earnings rating for Applied Genetic Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Genetic Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Genetic Technologies Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.93, ATR14 : 0.09, CCI20 : -231.52, Chaikin Money Flow : -0.11, MACD : -0.04, Money Flow Index : 47.52, ROC : -32.20, RSI : 28.33, STOCH (14,3) : 10.00, STOCH RSI : 0.00, UO : 40.88, Williams %R : -90.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Genetic Technologies Corporation in the last 12-months were: Gerald Anthony Reynolds (Sold 3 994 shares of value $3 376 ), Susan B. Washer (Option Excercise at a value of $55 810), Susan B. Washer (Sold 9 950 shares of value $21 691 )